We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Regulatory Readiness: Tips for Surviving Surveys and Staying in Compliance

By CLN Stat
Posted on 14 Dec 2020
Print article
Illustration
Illustration
Veteran accreditation insiders detail solutions for common deficiencies, pathway to improving quality of care.

An interactive scientific session at the 2020 AACC Annual Scientific Meeting & Clinical Lab Expo addresses the most common concerns cited across accrediting agencies that lead to noncompliance in laboratory medicine. Speakers plan to focus on competency assessment, one of the most common areas of citation.

Are You Meeting All the Regulatory Requirements? A Survival Guide for Laboratory Compliance takes place December 14 from 2 to 4:30 p.m. Central Standard Time. It’s worth 2 ACCENT credit hours.

Elia Mears, MS, MT (ASCP)SM, a lab surveyor for The Joint Commission, will discuss the quest for laboratory quality through competency assessment. Attendees will learn how to use regulatory assessment criteria to evaluate competency, identify those qualified to perform the assessment, and integrate the competency assessment program into their lab’s quality assessment plan, Mears told CLN Stat. She’ll also inform attendees about how to build a more robust competency assessment program. “Understanding CLIA roles is critical in the functioning of the laboratory,” she emphasized.

Brad Karon, MD, PhD, a professor of laboratory medicine and pathology at the Mayo Clinic, follows with a talk on the most common lab accreditation citations in the College of American Pathologists’ (CAP) accreditation program and ways to prevent common citations.

No matter how simple the lab test, errors can occur if it’s not performed correctly, leading to significant patient harm, Mears said. “Competency assessment is a focused approach to achieve confirmation that personnel training is effective and established procedures are followed, producing quality results.”

Specific educational requirements apply to personnel conducting lab tests under CLIA, noted Mears. “The exception is waived testing, which may be performed by anyone, following manufacturer instructions and good laboratory practice. For nonwaived testing, specific personnel roles, qualifications, and responsibilities are defined in the Federal Register Subpart M. Understanding the requirements as outlined in Subpart M may be confusing,” she noted.

Delegation of duties is a common area where labs fail, said Karon, who sits on CAP’s Continuous Compliance Committee, which sets requirements for labs to do proficiency testing (PT). This involves understanding which elements of the quality system have been delegated to which CLIA roles and making sure that delegated duties are carried out, he added. Reviewing PT results and corrective action for any missed PT challenges is another area cited often by regulatory and accrediting agencies.

Having a robust competency assessment program is essential, “especially for labs and hospitals with large point-of-care testing programs where many testing personnel are outside the walls of the conventional laboratory,” added Karon.

Participants will gain an understanding of how the CAP Laboratory Accreditation Program helps labs prevent common errors and quality gaps in the laboratory.

Related Links:
2020 AACC Annual Scientific Meeting
Are You Meeting All the Regulatory Requirements? A Survival Guide for Laboratory Compliance

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Uric Acid and Blood Glucose Meter
URIT-10
New
Piezoelectric Micropump
Disc Pump

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.